Adelia Razeto Selected Research

type 3 Rhizomelic chondrodysplasia punctata

6/2007

The crucial step in ether phospholipid biosynthesis: structural basis of a noncanonical reaction associated with a peroxisomal disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adelia Razeto Research Topics

Disease

2	Infections 09/2004 - 04/2004
1	Neoplasms (Cancer) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Disease Progression 01/2019
1	Huntington Disease (Huntington's Disease) 01/2019
1	type 3 Rhizomelic chondrodysplasia punctata 06/2007
1	Peroxisomal Disorders (Peroxisomal Disorder) 06/2007

Drug/Important Bio-Agent (IBA)

2	Anti-Bacterial Agents (Antibiotics)IBA 09/2004 - 04/2004
1	phosphatidylinositol 3,4,5-triphosphateIBA 01/2021
1	phosphoinositide-3,4-bisphosphateIBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	phosphatidylinositol 3,4-diphosphateIBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	Caspase 6IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	alkylglycerone-phosphate synthaseIBA 06/2007
1	Ether (Diethyl Ether)IBA 06/2007
1	Phospholipids (Phosphatides)FDA LinkGeneric 06/2007
1	ExotoxinsIBA 04/2004
1	PerforinIBA 04/2004